J. Margriet Collée

Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers

Mieke Kriege, Caroline Seynaeve, Hanne Meijers-Heijboer et al. · Journal of Clinical Oncology · 2009 · 103 citations · Full text

Medicine, Oncology, Pharmacology +15

Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers

Anouk Pijpe, Peggy Manders, Richard M. Brohet et al. · Breast Cancer Research and Treatment · 2009 · 99 citations · Full text

Medicine, Oncology, Cancer Genetics +11

Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients

Mieke Kriege, Caroline Seynaeve, Hanne Meijers‐Heijboer et al. · Breast Cancer Research and Treatment · 2007 · 35 citations

Medicine, Oncology, Breast Oncology +15

A counselee-oriented perspective on risk communication in genetic counseling: Explaining the inaccuracy of the counselees' risk perception shortly after BRCA1/2 test result disclosure

Joël Vos, Anne M. Stiggelbout, Jan C. Oosterwijk et al. · Genetics in Medicine · 2011 · 29 citations · Full text

Life Sciences, Counseling, Genetics +14

Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers

Mieke Kriege, Agnes Jager, Antoinette Hollestelle et al. · Journal of Cancer Research and Clinical Oncology · 2015 · 13 citations · Full text

Medicine, Oncology, Pharmacology +17